ArticleExperimental & molecular medicine2015

miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy.

Fang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.